Compounds > nicotine
Page last updated: 2024-08-26

nicotine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

nicotine has been researched along with 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emre, M; Hanagasi, HA; Johnson, JO; Lees, A; Singleton, A1
Brugières, P; Capacchione, D; Cesaro, P; Itti, E; Itti, L; Maison, P; Malek, Z; Meignan, M; Villafane, G1

Trials

1 trial(s) available for nicotine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

ArticleYear
Dopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study.
    Nuclear medicine communications, 2009, Volume: 30, Issue:7

    Topics: Administration, Cutaneous; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neostriatum; Nicotine; Parkinson Disease; Regression Analysis; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes

2009

Other Studies

1 other study(ies) available for nicotine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

ArticleYear
Smoking-responsive juvenile-onset Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Volume: 22, Issue:1

    Topics: Adult; Humans; Male; Nicotine; Nicotinic Agonists; Parkinsonian Disorders; Smoking; Tomography, Emission-Computed, Single-Photon; Tropanes

2007